BRNS Barinthus Bio Year-over-year net earnings per share growth for the last 12 months

Barinthus Biotherapeutics Corp - graphic logo of issuer BRNS

The absence of regular revenue due to clinical trials of T-cell therapies makes cash flows unpredictable for Barinthus Biotherapeutics (BRNS). Quarterly EPS dynamics demonstrate volatility, with the final value recorded at 51.50. Prospects rely on the development of hepatitis B vaccines, while sales reliability is guaranteed by diversified cold-chain logistics that minimize the spoilage of expensive immunotherapeutic drugs.

barinthusbio.com (BRNS) Year-over-year earnings per share growth for the last 12 months: for the period 02/21/2024 - 09/19/2026

Financial and market metric breakdowns for Barinthus Biotherapeutics (BRNS)

- market value and analyst target forecast:
Initial company analysis:Barinthus Biotherapeutics
Flagship merchandise of Barinthus Biotherapeutics Corp

Quarterly EPS growth measures the dynamics of net income per share, allowing for the differentiation of organic business expansion from one-time cost reductions. By analyzing the shift in quarterly EPS levels, an investor can see how Barinthus Biotherapeutics (BRNS) expenditures on environmental laboratory modernization and energy efficiency impact final returns, which determines the company's fundamental stability within the immunotherapy sector.

Who Barinthus Biotherapeutics competes with

argenx BVBA (ARGX) - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share growth for the last 12 months BioNTech SE|Year-over-year net earnings per share growth for the last 12 months ABVX|Quarterly EPS earnings growth admabiologics.com|Year-over-year earnings per share growth for the last twelve months Protagonist Therapeutics Inc (PTGX)|Immunovant - Year-over-year earnings per share growth for the last 12 months|Quarterly EPS earnings growth KNSA (kiniksa.com)|Grifols Group (GRFS) - Earnings per share growth in annualized terms for the last twelve months|Adaptive Biotechnologies Inc. - Quarterly EPS earnings growth|Celldex Therapeutics (CLDX) - Year-over-year net earnings per share growth for the last 12 months|AUPH (auriniapharma.com) - Year-over-year net earnings per share growth for the last 12 months|BCRX - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months Vera Pharma|Quarterly EPS earnings growth Dianthus Corp|Year-over-year earnings per share growth for the last twelve months Pharvaris N.V. (PHVS)|ABCL - Earnings per share growth in annualized terms for the last twelve months|Year-over-year earnings per share growth for the last twelve months Tourmaline Bio Inc TRML|Year-over-year net earnings per share change for the last twelve months Precigen (PGEN)|Pharming Corp - Quarterly EPS earnings growth|Year-over-year earnings per one share growth for the last 12 months NKTR (Nektar Therapeutics)|upstreambio.com (UPB) - Year-over-year earnings per share growth for the last twelve months|ZBIO (Zenas Biopharma Inc) - Year-over-year earnings per share growth for the last twelve months|IMNM (Immunome Bio) - Quarterly EPS earnings growth|GOSS: Year-over-year earnings per one share growth for the last 12 months|Year-over-year net earnings per share growth for the last 12 months KALV (KalVista Pharmaceuticals Inc)|SEPN (Septerna Corp) - Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth PVLA (Pieris Corp)|SVRA - Year-over-year net earnings per share growth for the last 12 months|RIGL - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per one share growth for the last 12 months ANAB (AnaptysBio)|ATXS: Quarterly EPS earnings growth|ENGN - Year-over-year net earnings per share change for the last twelve months|Year-over-year net earnings per share growth for the last 12 months RAPT|JBIO: Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months Aclaris Therapeutics (ACRS)|KYTX: Year-over-year net earnings per share trend for the last twelve months|Quarterly EPS earnings growth TLSA (Tiziana Life Sciences, Ltd.)|Year-over-year net earnings per share change for the last twelve months Cabaletta Bio Inc (CABA)|ventyxbio.com - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months theratech.com|AVTX: Quarterly EPS earnings growth|ELDN: Year-over-year earnings per share growth rate for the last twelve months|AGEN (Agenus, Inc) - Quarterly EPS earnings growth|Climb Bio, Inc. - Year-over-year net earnings per share trend for the last twelve months|Year-over-year earnings per share growth for the last twelve months Zura Bio (ZURA)|ATYR - Earnings per share growth in annualized terms for the last twelve months|Year-over-year earnings per share growth for the last twelve months Adagene ADAG|Year-over-year earnings per one share growth for the last 12 months IMA|STTK: Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per one share growth for the last 12 months EQ (equilliumbio.com)|Connect Biopharma Holdings Limited (CNTB) - Year-over-year earnings per share growth for the last twelve months|Immunic, Inc. (IMUX) - Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months ATRA|IFRX: Year-over-year earnings per one share growth for the last 12 months|X4 Pharmaceuticals Inc. (XFOR) - Year-over-year earnings per one share growth for the last 12 months|Year-over-year net earnings per share growth for the last 12 months Adicet ACET|Quarterly EPS earnings growth CELU (Celularity Inc)|Quarterly EPS earnings growth INmune Bio INMB|KZR - Year-over-year earnings per share growth for the last twelve months|SABS - Quarterly EPS earnings growth|Akari Therapeutics, Plc (AKTX) - Year-over-year earnings per share growth for the last twelve months|Enlivex Therapeutics, Ltd. (ENLV) - Quarterly EPS earnings growth|QTTB (Q32 Bio Inc) - Quarterly EPS earnings growth|geovax.com (GOVX) - Year-over-year net earnings per share change for the last twelve months|Year-over-year net earnings per share growth for the last 12 months EDSA (Edesa Biotech)|Year-over-year net earnings per share change for the last twelve months iBio Inc|Quarterly EPS earnings growth CARM (Carisma Therapeutics Inc)|Year-over-year earnings per one share growth for the last 12 months XTLB|BOLT: Year-over-year net earnings per share growth for the last 12 months|HCW Biologics (HCWB) - Year-over-year net earnings per share growth for the last 12 months|Aptevo (APVO) - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share growth for the last 12 months AIM ImmunoTech|Year-over-year net earnings per share growth for the last 12 months ADTX|GRI Bio Corporation (GRI) - Year-over-year net earnings per share change for the last twelve months|Year-over-year net earnings per share growth for the last 12 months XRTX (XORTX Therapeutics Inc.)|Vyome Holdings Inc - Year-over-year earnings per share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months Revelation Biosciences Inc REVB|INDP - Year-over-year net earnings per share growth for the last 12 months|SCNI: Year-over-year net earnings per share growth for the last 12 months|CALI: Year-over-year earnings per share growth for the last twelve months|AFMD: Quarterly EPS earnings growth|Allakos Inc - Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months HOOKIPA Pharma, Inc.|IGM Biosciences, Inc. (IGMS) - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months iteostherapeutics.com (ITOS)|OCEA - Earnings per share growth in annualized terms for the last twelve months|TC BioPharm (Holdings) PLC - Year-over-year net earnings per share growth for the last 12 months|THRD: Year-over-year earnings per share growth for the last 12 months